1. Home
  2. ADVM vs FTEK Comparison

ADVM vs FTEK Comparison

Compare ADVM & FTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • FTEK
  • Stock Information
  • Founded
  • ADVM 2006
  • FTEK 1987
  • Country
  • ADVM United States
  • FTEK United States
  • Employees
  • ADVM N/A
  • FTEK N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • FTEK Pollution Control Equipment
  • Sector
  • ADVM Health Care
  • FTEK Industrials
  • Exchange
  • ADVM Nasdaq
  • FTEK Nasdaq
  • Market Cap
  • ADVM 47.4M
  • FTEK 47.1M
  • IPO Year
  • ADVM 2014
  • FTEK N/A
  • Fundamental
  • Price
  • ADVM $2.39
  • FTEK $2.79
  • Analyst Decision
  • ADVM Strong Buy
  • FTEK Strong Buy
  • Analyst Count
  • ADVM 5
  • FTEK 1
  • Target Price
  • ADVM $23.80
  • FTEK $4.00
  • AVG Volume (30 Days)
  • ADVM 338.5K
  • FTEK 528.7K
  • Earning Date
  • ADVM 08-11-2025
  • FTEK 08-05-2025
  • Dividend Yield
  • ADVM N/A
  • FTEK N/A
  • EPS Growth
  • ADVM N/A
  • FTEK N/A
  • EPS
  • ADVM N/A
  • FTEK N/A
  • Revenue
  • ADVM $1,000,000.00
  • FTEK $26,558,000.00
  • Revenue This Year
  • ADVM N/A
  • FTEK $21.36
  • Revenue Next Year
  • ADVM $18.82
  • FTEK $11.03
  • P/E Ratio
  • ADVM N/A
  • FTEK N/A
  • Revenue Growth
  • ADVM N/A
  • FTEK 7.30
  • 52 Week Low
  • ADVM $1.78
  • FTEK $0.87
  • 52 Week High
  • ADVM $10.14
  • FTEK $2.96
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 44.19
  • FTEK 69.37
  • Support Level
  • ADVM $2.11
  • FTEK $2.38
  • Resistance Level
  • ADVM $2.60
  • FTEK $2.96
  • Average True Range (ATR)
  • ADVM 0.22
  • FTEK 0.26
  • MACD
  • ADVM -0.00
  • FTEK 0.04
  • Stochastic Oscillator
  • ADVM 33.33
  • FTEK 86.78

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

About FTEK Fuel Tech Inc.

Fuel Tech Inc is an technology provider of boiler optimization, efficiency improvement, and air pollution reduction to utility and industrial customers. The company operates in two segments, Air Pollution Control and Fuel Chem. The Air Pollution Control technology segment includes technologies to reduce NOx emissions in flue gas from boilers, incinerators, furnaces and other stationary combustion sources. The Fuel Chem technology segment uses chemical processes in combination with Computational Fluid Dynamics and Chemical Kinetics Modeling boiler modeling for the control of slagging, fouling, corrosion, opacity and other sulfur trioxide-related issues in furnaces and boilers through the addition of chemicals into the furnace using TIFI Targeted In-Furnace Injection technology.

Share on Social Networks: